Getting The Public Invested In Science

New Embryonic Stem Cell Policy

New guidelines for the use of embryonic stem cells have been proposed by the National Institutes of Health. Many scientists were excited when President Barack Obama announced on March 9th that restrictions enforced by the Bush administration would be overturned. Under the Bush administration policy, only 21 embryonic stem cell lines that had been established prior to August 2001 qualified for federal funding. The new policy draft was released April 18th and, after much scrutiny from the science community, has been deemed by many scientists to be even more restrictive than the Bush administration policy.

The new policy requires consent forms that specifically mention human embryonic stem cell research, forbid donating eggs for the benefit of a specific person, and contain multiple other stipulations that were generally mentioned on older consent forms, but not specifically defined. The new rules are to be applied retroactively to existing embryonic stem cell lines, and therefore could have a serious impact on existing and proposed research. In fact, the vast majority of the 700+ existing embryonic stem cell lines would be ineligible for federal funding under the new policy.

The NIH has issued a Request for Comment in regards to the proposed “Draft National Institutes of Health Guidelines for Human Stem Cell Research Notice”. Prior to enacting these changes, the NIH must obtain public comment. These comments are taken seriously in determining whether the proposed changes will be enacted.

Stem cell research has been a hotly debated issue and responding to the request for comment is a way for individuals, scientists and lay-persons, to have a say in the discussion. We encourage you to make your voice heard.

The deadline for a response is May 26, 2009. The notice can be found at: http://edocket.access.gpo.gov/2009/E9-9313.htm. You may submit a comment through the following website: http://nihoerextra.nih.gov/stem_cells/add.htm.

Tags:
| May 15th, 2009 by Daniel Gaddy | Posted in Life Sciences |


Comments are closed.


Copyright 2010 FundScience LLC